http://en.people.cn/n3/2024/0525/c90000-20174097.html

A genetically modified pig liver was successfully implanted into a living human patient with severe liver cancer. The operation was conducted on May 17 by a team led by Professor Sun Beicheng from Hefei Hospital, in collaboration with a team led by Professor Wei Hongjiang from Yunnan Agricultural University.

The 71-year-old patient with liver cancer is said not to have  experienced acute or hyperacute rejection within the seven days following the operation, nor did he experience a disorder in his coagulation system. The patient is able to move around freely at present, and his liver function and many other health indicators have returned to normal.

In April, Chinese researchers successfully transplanted a genetically modified pig liver into a brain-dead patient at Xijing Hospital of the Air Force Medical University in Xi’an, transplanting a pig liver into a brain-dead human for the first time in the field of medicine.